{"disease":{"id":"primary-raynaud-phenomenon","name":"primary raynaud phenomenon"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02202291","title":"Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon","phase":"NA","overall_status":"COMPLETED","enrollment_count":258,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT03211325","title":"Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT03815162","title":"Cocoa Flavanol Supplementation in Raynaud's Phenomenon","phase":"NA","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT03869008","title":"Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.","phase":"NA","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"University of Toledo Health Science Campus","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}